These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 23036054)

  • 1. Targeting the estrogen receptor using steroid-therapeutic drug conjugates (hybrids).
    Dao KL; Hanson RN
    Bioconjug Chem; 2012 Nov; 23(11):2139-58. PubMed ID: 23036054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, cytocidal activity and estrogen receptor α affinity of doxorubicin conjugates at 16α-position of estrogen for site-specific treatment of estrogen receptor positive breast cancer.
    Saha P; Fortin S; Leblanc V; Parent S; Asselin É; Bérubé G
    Steroids; 2012 Sep; 77(11):1113-22. PubMed ID: 22801351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen receptors: selective ligands, partners, and distinctive pharmacology.
    Katzenellenbogen BS; Montano MM; Ediger TR; Sun J; Ekena K; Lazennec G; Martini PG; McInerney EM; Delage-Mourroux R; Weis K; Katzenellenbogen JA
    Recent Prog Horm Res; 2000; 55():163-93; discussion 194-5. PubMed ID: 11036937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Membrane-initiated steroid signaling action of estrogen and breast cancer.
    Song RX
    Semin Reprod Med; 2007 May; 25(3):187-97. PubMed ID: 17447208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen receptor-binding affinity and cytotoxic activity of three new estrogen-nitrosourea conjugates in human breast cancer cell lines in vitro.
    Lam HY; Ng PK; Goldenberg GJ; Wong CM
    Cancer Treat Rep; 1987 Oct; 71(10):901-6. PubMed ID: 3652053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steroid hormone receptors as targets for the therapy of breast and prostate cancer--recent advances, mechanisms of resistance, and new approaches.
    Hoffmann J; Sommer A
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):191-200. PubMed ID: 15860262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiestrogen binding site and estrogen receptor mediate uptake and distribution of 4-hydroxytamoxifen-targeted doxorubicin-formaldehyde conjugate in breast cancer cells.
    Burke PJ; Kalet BT; Koch TH
    J Med Chem; 2004 Dec; 47(26):6509-18. PubMed ID: 15588086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear estrogen receptor targeted photodynamic therapy: selective uptake and killing of MCF-7 breast cancer cells by a C17alpha-alkynylestradiol-porphyrin conjugate.
    Swamy N; Purohit A; Fernandez-Gacio A; Jones GB; Ray R
    J Cell Biochem; 2006 Oct; 99(3):966-77. PubMed ID: 16741968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogenic and antiestrogenic activities of flavonoid phytochemicals through estrogen receptor binding-dependent and -independent mechanisms.
    Collins-Burow BM; Burow ME; Duong BN; McLachlan JA
    Nutr Cancer; 2000; 38(2):229-44. PubMed ID: 11525602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular basis of steroid hormone action in breast cancer and its clinical implications.
    Lunenfeld B; Geier A
    Isr J Med Sci; 1981; 17(9-10):954-9. PubMed ID: 7031015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Steroid conjugates of dichloro(6-aminomethylnicotinate)platinum(II): effects on DNA, sex hormone binding globulin, the estrogen receptor, and various breast cancer cell lines.
    Schobert R; Bernhardt G; Biersack B; Bollwein S; Fallahi M; Grotemeier A; Hammond GL
    ChemMedChem; 2007 Mar; 2(3):333-42. PubMed ID: 17266159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-estrogens in the treatment of breast cancer: current status and future directions.
    Barker S
    Curr Opin Investig Drugs; 2003 Jun; 4(6):652-7. PubMed ID: 12901222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective estrogen receptor modulators (SERMs): mechanisms of anticarcinogenesis and drug resistance.
    Lewis JS; Jordan VC
    Mutat Res; 2005 Dec; 591(1-2):247-63. PubMed ID: 16083919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis and biological evaluation of novel estrogen-derived steroid metal complexes.
    Zhang X; Zuo Z; Tang J; Wang K; Wang C; Chen W; Li C; Xu W; Xiong X; Yuntai K; Huang J; Lan X; Zhou HB
    Bioorg Med Chem Lett; 2013 Jul; 23(13):3793-7. PubMed ID: 23726343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
    Menendez JA; Oza BP; Colomer R; Lupu R
    Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The biological significance of the interaction of estrogen agonists and antagonists with the estrogen receptor.
    Murphy CS; Jordan VC
    Receptor; 1990-1991 Winter; 1(1-2):65-82. PubMed ID: 2152373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endocrine-responsive breast cancer and strategies for combating resistance.
    Ali S; Coombes RC
    Nat Rev Cancer; 2002 Feb; 2(2):101-12. PubMed ID: 12635173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual roles of estrogen metabolism in mammary carcinogenesis.
    Chang M
    BMB Rep; 2011 Jul; 44(7):423-34. PubMed ID: 21777512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proliferation, hormonal responsiveness, and estrogen receptor content of MCF-7 human breast cancer cells grown in the short-term and long-term absence of estrogens.
    Katzenellenbogen BS; Kendra KL; Norman MJ; Berthois Y
    Cancer Res; 1987 Aug; 47(16):4355-60. PubMed ID: 3607768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basic guide to the mechanisms of antiestrogen action.
    MacGregor JI; Jordan VC
    Pharmacol Rev; 1998 Jun; 50(2):151-96. PubMed ID: 9647865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.